| Item | Value |
|---|---|
| DrugBank ID | DB00833 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 30 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | pneumonia | TxGNN Knowledge Graph |
| 2 | pharyngitis | TxGNN Knowledge Graph |
| 3 | staphylococcus aureus infection | TxGNN Knowledge Graph |
| 4 | streptococcal infection | TxGNN Knowledge Graph |
| 5 | staphylococcal infection | TxGNN Knowledge Graph |
| 6 | streptococcal pneumonia | TxGNN Knowledge Graph |
| 7 | urinary tract infection (disease) | TxGNN Knowledge Graph |
| 8 | common cold | TxGNN Knowledge Graph |
| 9 | tonsillitis | TxGNN Knowledge Graph |
| 10 | respiratory tract infectious disease | TxGNN Knowledge Graph |
| 11 | pneumonia | TxGNN Knowledge Graph |
| 12 | pharyngitis | TxGNN Knowledge Graph |
| 13 | staphylococcus aureus infection | TxGNN Knowledge Graph |
| 14 | streptococcal infection | TxGNN Knowledge Graph |
| 15 | staphylococcal infection | TxGNN Knowledge Graph |
| 16 | streptococcal pneumonia | TxGNN Knowledge Graph |
| 17 | urinary tract infection (disease) | TxGNN Knowledge Graph |
| 18 | common cold | TxGNN Knowledge Graph |
| 19 | tonsillitis | TxGNN Knowledge Graph |
| 20 | respiratory tract infectious disease | TxGNN Knowledge Graph |
| 21 | pneumonia | TxGNN Knowledge Graph |
| 22 | pharyngitis | TxGNN Knowledge Graph |
| 23 | staphylococcus aureus infection | TxGNN Knowledge Graph |
| 24 | streptococcal infection | TxGNN Knowledge Graph |
| 25 | staphylococcal infection | TxGNN Knowledge Graph |
| 26 | streptococcal pneumonia | TxGNN Knowledge Graph |
| 27 | urinary tract infection (disease) | TxGNN Knowledge Graph |
| 28 | common cold | TxGNN Knowledge Graph |
| 29 | tonsillitis | TxGNN Knowledge Graph |
| 30 | respiratory tract infectious disease | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.